Mutational activation of the β-catenin proto-oncogene is a common event in the development of Wilms' tumors

Cancer Research

Volumn 59, Issue 16, 1999, Pages 3880-3882

  Koesters, Robert ^a   Ridder, Ruediger ^a   Kopp Schneider, Annette ^b   Betts, David ^c   Adams, Volker ^d   Niggli, Felix ^c   Briner, Jakob ^e   Doeberitz, Magnus Von Knebel ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Children's Hospital Zurich   (Switzerland)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e Institute for Histological and Cytological Diagnostics   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

ARTICLE; CELL TRANSFORMATION; DNA SEQUENCE; EPITHELIUM CELL; GENE DELETION; GENE MUTATION; GENE TARGETING; HUMAN; HUMAN TISSUE; KIDNEY DEVELOPMENT; NEPHROBLASTOMA; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; SIGNAL TRANSDUCTION;

BETA CATENIN; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENES, WILMS TUMOR; HUMANS; KIDNEY NEOPLASMS; MUTATION; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; WILMS TUMOR; WNT PROTEINS;

EID: 0033566764     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Knudson, A. G., Jr., and Strong, L. C. Mutation and cancer: a model for Wilms' tumor of the kidney. J. Natl. Cancer Insy., 48: 313-324, 1972.
2. van Heyningen, V., et al. Molecular analysis of chromosome 11 deletions in aniridia-Wilms' tumor syndrome. Proc. Natl. Acad. Sci. USA, 82: 8592-8596, 1985.
3. Mannens, M., et al. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumors. Hum. Genet., 81: 41-48, 1988.
4. Maw, M. A., et al. A third Wilms' tumor locus on chromosome 16q. Cancer Res., 52: 3094-3098, 1992.
5. Steenman, M., et al. Comparative genomic hybridization analysis of Wilms' tumors. Cytogenet. Cell Genet., 77: 296-303, 1997.
6. Grundy, P. E., et al. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res., 54: 2331-2333, 1994.
7. Call, K. M., et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60: 509-520, 1990.
8. Gessler, M., et al. Homozygous deletion in Wilms' tumors of a zinc-finger gene identified by chromosome jumping. Nature (Lond.), 343: 774-778, 1990.
9. Pelletier, J., et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell, 67: 437-447, 1991.
10. Varanasi, R., et al. Fine structure analysis of the WT1 gene in sporadic Wilms' tumors. Proc. Natl. Acad. Sci. USA, 91: 3554-3558, 1994.
11. Munemitsu, S., Albert, I., Rubinfeld, B., and Polakis, P. Deletion of an amino-terminal sequence stabilizes β-catenin in vivo and promotes hyperphosphorylation of the adenomatous polyposis coli tumor suppressor protein. Mol. Cell. Biol., 16: 4088-4096, 1996.
12. Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16: 3797-3805, 1997.
13. Robbins, P. F., et al. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med., 183: 1185-1192, 1996.
14. Morin, P. J., et al. Activation of β-catenin/Tcf signaling in colon cancer by mutations in β-catenin or APC. Science (Washington DC), 275: 1787-1790, 1997.
15. Kitaeva, M. N., et al. Mutations in β-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res., 57: 4478-4481, 1997.
16. Sparks, A. B., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Mutational analysis of the APC/β catenin/Tcf pathway in colorectal cancer. Cancer Res., 58: 1130-1134, 1998.
17. Miyoshi, Y., et al. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res., 58: 2524-2527, 1998.
18. Kispert, A., Vainio, S., and McMahon, A. P. Wnt-4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development (Camb.), 125: 4225-4234, 1998.
19. Krieg, P., Amtmann, E., and Sauer, G. The simultaneous extraction of high-molecular-weight DNA and of RNA from solid tumors. Anal. Biochem., 134: 288-294, 1983.
20. Koesters, R., et al. Mutational analysis of the tumor suppressor gene WT1: detection of a novel homozygous point mutation in sporadic unilateral Wilms' tumor. Int. J. Oncol., 7: 1103-1107, 1995.
21. Stallmach, T., Neuhaus T. J., Koesters, R., and Hailemariam, S. Glomerulopathy in Denys-Drash syndrome. Case report of a model disease. Pathologe, 19: 230-234, 1998.
22. Bullions, L. C., and Levine, A. J. The role of β-catenin in cell adhesion, signal transduction, and cancer. Curr. Opin. Oncol., 10: 81-87, 1998.
23. He, T. C., et al. Identification of c-MYC as a target of the APC pathway. Science (Washington DC), 281: 1509-1512, 1998.
24. Tetsu, O., and McCormick, F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature (Lond.), 398: 422-426, 1999.
25. Bardeesy, N., et al. Anaplastic Wilms' tumor, a subtype displaying poor prognosis, harbors p53 gene mutations. Nat. Genet., 7: 91-97, 1994.